An open-label, single-arm, prospective study to evaluate the lipid-lowering efficacy and safety of simvastatin 40 mg tablet in patients with hypercholesterolemia.
Phase of Trial: Phase IV
Latest Information Update: 13 Apr 2017
At a glance
- Drugs Simvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Merck & Co
- 01 Feb 2007 Status changed from recruiting.
- 13 Dec 2006 New trial record.